Építés alatt – nem éles oldal
Belépés
Taking people in Egyesült ÁllamokNo phase

Anifrolumab Pregnancy Study

Key facts

Where
Cary, Egyesült ÁllamokSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 130 years old?

Forrás: NCT07049653: ki vehet részt

Where in Egyesült Államok

  • CaryCary, Egyesült ÁllamokTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
AstraZeneca
Trial code
NCT07049653
Record updated
2026. szeptember 18.
Original description
This is a non-interventional multi-database post-authorisation study to assess pregnancy-related safety data from women with SLE exposed to Anifrolumab.Read full original descriptionShow less

A Non-Interventional Multi-Database Post-Authorisation Study to Assess Pregnancy-Related Safety Data From Women With SLE Exposed to Anifrolumab

This is a non-interventional multi-database post-authorisation study to assess pregnancy-related safety data from women with SLE exposed to Anifrolumab.

Inclusion: Women with a continuous enrolment in the database for ≥ 12 months prior to LMP2; Women diagnosed with SLE before pregnancy; Women exposed to anifrolumab (polytherapy, added to SLE SOC) during pregnancy and/or 16-week period prior to LMP2; Women with a continuous enrolment in the database for ≥ 12 months prior to LMP2; Women diagnosed with SLE before pregnancy; Women treated with SLE SOC during pregnancy; Women with moderate/severe SLE.

Exclusion: Women treated with anifrolumab during pregnancy and/or 16-week period prior to LMP2; Women prescribed a confirmed teratogenic drug prior to LMP2 with a time period of 5-half-lives of relevant drug or during pregnancy; Women with a history of CM or chromosomal abnormalities (according to available records), before delivery; Pregnancies whose date of conception cannot be established; Pregnancies whose date of conception cannot be established.

ClinicalTrials.gov NCT07049653